Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
AUTOR(ES)
Board, R E
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778539Documentos Relacionados
- Clinical significance of BRAF mutations in metastatic melanoma
- B-Raf specific antibody responses in melanoma patients
- Phase II study of sunitinib in men with advanced prostate cancer
- Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
- Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer